0

Global Immuno-oncology assay Market Expected to Reach $6,179 Million by 2026

 
2022
Global Immuno-oncology assay Market

Report Code : A06079

quote Significant increase in R&D pertaining to the development of novel drugs and biomarkers across the globe drives the market growth for immuno-oncology assays market. Moreover, surge in incidence of cancer across the globe is a key factor that propels the growth of the global market. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, "Immuno-oncology Assay Market by Product, Application, Indication, and Technology: Global Opportunity Analysis and Industry Forecast, 2019–2026," The global immuno-oncology assays market size accounted for $2,769 million in 2018, and is expected to reach 6,179 million by 2026, growing at a CAGR of 10.6% from 2019 to 2026. North America was the highest revenue contributor in 2018 and is anticipated to continue this trend throughout the forecast period.

Immuno-oncology is an area of scientific research involved in investigating that how immune system can fight cancers. It is a procedure used to find out the potential of the immune system to fight against cancer cells. Further, cancer has become one the most frequent causes of mortality in western industrialized countries. Immune oncological approaches are serving to determine new potent curative cancer treatment that could possibly even lead to the eradication of most types of cancer.

The major factors which drive the growth of this market include significant rise in cancer incidence across the globe and increase in R&D activities for the developing cancer treatments. However, dearth of skilled labor and high capital investment are anticipated to restrain the immune-oncology assay market growth during the forecast period. On the contrary, increased focus on developing automated immuno-oncology assay is anticipated to create lucrative opportunities in the near future.

The global immuno-oncology assay market in this report is studied based on product, technology, indication, application, and region. On the basis of product, the market is divided into consumables and software. By technology, the market is classified into immunoassay, polymerase chain reaction (PCR), next generation sequencing (NGS), flow cytometry and others. Based on indication, it is bifurcated into colorectal cancer, lung cancer, melanoma, bladder cancer and others. By application it is segmented into clinical diagnostics, research. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Based on product, the consumables segment held the largest share of 60% in 2018 and is anticipated to remain the same during the forecast period, due to the usage of several kinds of reagents, kits, instruments for performing the assays. However, software segment is anticipated to grow at the fastest rate during the forecast period.

By technology, the PCR segment accounted for the majority of immuno-oncology assay market share and is anticipated to continue its dominance during the forecast period. This is attributed to the wide usage of PCR while performing oncology diagnosis and research. In addition, technological advancements in PCR technology such as advent of real time PCR further contributes to the immuno-oncology assay market growth.

Key Findings of the Study:

  • Depending on product, consumables was the leading segment of the global immune-oncology assay market in 2018, and is projected to grow at a CAGR of 10.2% during the forecast period.
  • North America accounted for the share of 42% of the market in 2018, and is projected to grow at a CAGR of 10.1%.
  • By technology, the PCR segment accounted for the largest market share of 60% in 2018.
  • As per application, the research segment held the highest market share in 2018, and is expected to lead the market during the analysis period.

Region wise, North America was the highest revenue generator with a share of 44% in 2018. This is attributed to increase in expenditure in R&D, presence of well-established healthcare infrastructure, and higher demand for technically advanced devices for research. However, the Asia-Pacific region is projected to grow with the highest CAGR of 12.2% during the analysis period, owing to surge in healthcare expenditure, increase in per capita income, and improvement in healthcare infrastructure.

The major players operating in the global immuno-oncology assays market are Agilent Technologies, F. Hoffmann-La Roche, HTG Molecular Diagnostics, Illumina, Merck, NanoString Technologies, PerkinElmer, Qiagen, Sartorius, and Thermo Fisher Scientific. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies to strengthen their foothold in the market

 

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Immuno-oncology Assay Market by Product (Consumables and Software), by Technology (Immunoassays, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Flow Cytometry), Application (Research & Development and Clinical Diagnostics), and Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Jul 2024

Body Mist Market

Download Sample
rep-img

Published Date Jul 2024

Crop Reinsurance Market

Download Sample

Buy Full Version
"Global Immuno-oncology assay Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers